collection type: Hospital,Longitudinal,Sample collection,Other | disease: Pneumonia due to staphylococcus aureus | data categories: Physiological/Biochemical measurements | materials: Not available | omics: Not available | imaging: N | sex: Female,Male
We investigated whether hyperaggregation occurs during infection, and whether aspirin inhibits this. Patients hospitalised due to acute infection were randomised to receive 10 days of aspirin treatment or no intervention. Our outcome measures were PFA-Closure Time, serum thromboxane and plasma thromboxane.
The efficacy of aspirin to inhibit platelet aggregation in patients hospitalised with a severe infection: a multicentre, open‑label, randomised controlled trial
ASPIRIN
Female
Hospital
Longitudinal
Male
Not available
Other
Physiological Biochemical measurements
Pneumonia due to staphylococcus aureus
Sample collection